Company / Shareholders' Equity
CorMedix Inc. Shareholders' Equity History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Shareholders' Equity
$405.3M
FY2025
5-year range
$44.2M / $405.3M
FY2021-FY2025
Trend
+378.8%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Shareholders' Equity changed +379% YoY in FY2025, a notable deviation from the 9-year average annual change of +87%.
Based on SEC 10-K filings.
$405M in FY2025 with a 5-year CAGR of +76.5%.
Improved from $70M to $405M over the past 2 years.
Shareholders' Equity over time
Growth rates
- 3-Year CAGR
- +86.2%
- 5-Year CAGR
- +76.5%
- 10-Year CAGR
- -
Key checks
Key Insights
- CorMedix Inc.'s shareholders' equity has grown for 6 consecutive years.
- 5-year CAGR of +76.5%, indicating consistent growth.
- In FY2025, shareholders' equity increased 378.8% year-over-year.
- Lowest shareholders' equity in the period was in FY2019.
Annual data
| Year | Shareholders' EquityValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $405.3M | +378.8% |
| FY2024 | $84.7M | +20.7% |
| FY2023 | $70.1M | +11.7% |
| FY2022 | $62.8M | +42.0% |
| FY2021 | $44.2M | +87.0% |
| FY2020 | $23.6M | +379.2% |
| FY2019 | $4.9M | -31.4% |
| FY2018 | $7.2M | -59.6% |
| FY2017 | $17.8M | -47.6% |
| FY2016 | $34.0M | +0.0% |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026